Sellbyville, DE -- (SBWIRE) -- 11/29/2018 -- Global HLA Typing for Transplant Market is set to exceed USD 720 million by 2024; according to a new research study published by Global Market Insights, Inc.

HLA typing for transplant market is slated to witness lucrative growth over the forecast timeframe. Growing demand for solid organ transplants will drive HLA typing for transplant industry growth over the forecast years. These lifesaving transplants are indispensable for treating patients suffering from heart, liver, lung, kidney disorders as they help to increase patient survival.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1653

Molecular assays segment is slated to exhibit robust growth over the forecast timeframe owing to the increasing adoption of these tests. Non-molecular methods such as serological assays and mixed lymphocyte culture assays were earlier considered to be gold standard for HLA typing. However, faster and more accurate molecular methods are replacing the non-molecular ones at a rapid pace. Introduction of advanced methods such as next generation sequencing which is capable of processing large amount of sequences in a single run will further propel adoption.

Reagents and consumables industry segment held significant industry share in 2016 and is poised to grow at a rapid pace during the forecast timeframe as they are required in large quantities for HLA typing.
Application of HLA typing in research is slated to increase at a lucrative pace owing to the spur in research and development activities being carried out to develop methods which are more advanced and accurate as compared to existing ones. Hospital end user segment will grow at a rapid pace owing to the increasing number of organ transplant procedures being performed in these settings. Growing number of hospitals in several countries because of the healthcare infrastructure expansion plans will further augment segment growth.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- CareDx, Inc.
- Bio-Rad Laboratories
- Bio Reference Laboratories Inc
- GenDx
- Pacific Biosciences Inc.
- Immucor
- QIAGEN
- inno-train Diagnostik
- Luminex Corporation
- Omixon
- Kalila Medical (Abbott Laboratories)

U.S. HLA typing for transplant market held significant industry share in 2016. The large share is attributable to the growing number of organ transplant procedures. Increasing life expectancy and the consequential spur in geriatric population base will further boost industry growth. Increasing HLA typing product approvals from regulatory bodies is leading to availability of advanced products in the region, in turn fostering growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1653

HLA Typing for Transplant Market by Technology
- Non-Molecular Assays
- Serological Assays
- Mixed Lymphocyte Culture Assays
- Molecular Assays
- PCR Based Molecular Assays
- Sequencing Based Molecular Assays
- Sanger Sequencing
- Next Generation Sequencing

HLA Typing for Transplant Market by Product and Services
- Instruments
- Reagents and Consumables
- Software
- Services